ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 1253731-24-6
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Signaling Pathways
  6. rel-(2S,3R)-Voruciclib

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product Name2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one
Synonyms3R)-Voruciclib;(2S,3R)-Voruciclib;2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one
CAS1253731-24-6
EINECS
Chemical FormulaC22H19ClF3NO5
Molecular Weight469.8381696
inchi
PackageInquiry
PriceGet quote
Descriptionsrel-(2S,3R)-Voruciclib

rel-(2S,3R)-Voruciclib

MedChemExpress (MCE)

HY-12422C

1253731-24-6

Please store the product under the recommended conditions in the Certificate of Analysis.

Room temperature in continental US

Descriptions

rel-(2S,3R)-Voruciclib

rel-(2S,3R)-Voruciclib

MedChemExpress (MCE)

HY-12422C

1253731-24-6

Please store the product under the recommended conditions in the Certificate of Analysis.

Room temperature in continental US
may vary elsewhere.

rel-(2S,3R)-Voruciclib is the (2S,3R)-enantiomer of Voruciclib. (2S,3R)-Voruciclib is an orally active CDK inhibitor.

rel-(2S,3R)-Voruciclib (Compound B, formula I) is used in combination with a compound capable of inhibiting EGFR kinase activity and Gemcitabine to treat pancreatic cancer[1].

CDK[1] In Vitro rel-(2S,3R)-Voruciclib (Compound B, formula I) is used in combination with a compound capable of inhibiting EGFR kinase activity and Gemcitabine to treat pancreatic cancer[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> rel-(2S,3R)-Voruciclib Related Antibodies

| | | |

| | | | | |



[1]. Veena Agarwal, et al. A synergistic pharmaceutical combination for the treatment of pancreatic cancer. WO2012123889A1.

Supplier Websitehttps://www.medchemexpress.com/rel-2s-3r-voruciclib.html
Last Update2025-05-21 16:50:25
MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-05-21 16:50:25

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-05-21 16:50:25

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-05-21 16:50:25

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-05-21 16:50:25

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-05-21 16:50:25

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-05-21 16:50:25

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-05-21 16:50:25

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-05-21 16:50:25
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002